Evidence for cAMP-independent mechanisms mediating the effects of adrenomedullin, a new inotropic peptide

Circulation

Volumn 97, Issue 11, 1998, Pages 1062-1070

  Szokodi, István ^a   Kinnunen, Pietari ^b   Tavi, Pasi ^b   Weckström, Matti ^b   Tóth, Miklós ^a   Ruskoaho, Heikki ^b  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

Adrenomedullin; Calcium; Contractility; Peptides; Signal transduction

Indexed keywords

ADRENOMEDULLIN; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CALCITONIN GENE RELATED PEPTIDE[8-37]; CALCIUM CHANNEL; CALCIUM ION; CYCLIC AMP; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PROADRENOMEDULLIN; PROTEIN KINASE C; RYANODINE; STAUROSPORINE; THAPSIGARGIN;

ACTION POTENTIAL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CALCIUM TRANSPORT; CONTROLLED STUDY; DOSE RESPONSE; ELECTROPHYSIOLOGY; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HUMAN; INOTROPISM; ISOLATED HEART; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; SIGNAL TRANSDUCTION;

EID: 0032562258     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.11.1062     Document Type: Article

References (59)

1. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamara S, Matsuo H, Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun. 1993;192:553-560.
2. Schell DA, Vari RC, Samson WK. Adrenomedullin: a newly discovered hormone controlling fluid and electrolyte homeostasis. Trends Endocrinol Metab. 1996;7:7-13.
3. Richards AM, Nichols MG, Lewis L, Lainchbury JG. Adrenomedullin. Clin Sci. 1996;91:3-16.
4. Sakata J, Shimokubo T, Kitamura K, Nakamura S, Kangawa K, Matsuo H, Eto T. Molecular cloning and biological activities of rat adrenomedullin, a hypotensive peptide. Biochem Biophys Res Commun. 1993;195:921-927.
5. Jougasaki M, Wei CM, McKinley LJ, Burnett JC Jr. Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation. 1995;92:286-289.
6. Sakata J, Shimokubo T, Kitamura K, Nishizono M, Ichiki Y, Kangawa K, Matsuo H, Eto T. Distribution and characterization of immunoreactive rat adrenomedullin in tissue and plasma. FEBS Lett. 1994;352:105-108.
7. Ichiki Y, Kitamura K, Kangawa K, Kawamoto M, Matsuo H, Eto T. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett. 1994;338:6-10.
8. Owji AA, Smith DM, Coppock HA, Morgan DGA, Bhogal R, Ghatel MA, Bloom SR. An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat. Endocrinology. 1995;136:2127-2134.
9. Parkes DG. Cardiovascular actions of adrenomedullin in conscious sheep. Am J Physiol. 1995;268:H2574-H5278.
10. Parkes DG, May CN. Direct cardiac and vascular actions of adrenomedullin in conscious sheep. Br J Pharmacol. 1997;120:1179-1185.
11. Szokodi I, Kinnunen P, Ruskoaho H. Inotropic effect of adrenomedullin in the isolated perfused rat heart. Acta Physiol Scand. 1996;156:151-152.
12. Nishikimi T, Saito Y, Kitamura K, Ishimitsu T, Eto T, Kangawa K, Matsuo H, Omae T, Matsuoka H. Increased plasma levels of adrenomedullin in patients with heart failure. J Am Coll Cardiol. 1995;26: 1424-1431.
13. Kato J, Kobayashi K, Etoh T, Tanaka M, Kitamura K, Imamura T, Koiwaya Y, Kangawa K, Eto T. Plasma adrenomedullin concentration in patients with heart failure. J Clin Endocrinol Metab. 1996;81:180-183.
14. Jougasaki M, Rodeheffer RJ, Redfield MM. Yamamoto K, Wei CM, McKinley LJ, Burnett JC Jr. Cardiac secretion of adrenomedullin in human heart failure. J Clin Invest. 1996;97:2370-2376.
15. Eguchi S, Hirata Y, Kano H, Sato K, Watanabe Y, Watanabe TX, Nakajima K, Sakakibara S, Marumo F. Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells. FEBS Lett. 1994;340:226-230.
16. Ishizaka Y, Tanaka M, Kitamura K, Kangawa K, Minamino N, Matsuo H, Eto T. Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells. Biochem Biophys Res Commun. 1994;200:642-646.
17. 2+ mobilization, in bovine aortic endothelial cells. J Biol Chem. 1995;270:4412-4417.
18. Chini EN, Choi E, Grande JP, Burnett JC, Dousa TP. Adrenomedullin suppresses mitogenesis in rat mesangial cells via cAMP pathway. Biochem Biophys Res Commun. 1995;215:868-873.
19. Ikeda U, Kanbe T, Kawahara Y, Yokoyama M, Shimada K. Adrenomedullin augments inducible nitric oxide synthase expression in cytokine-stimulated cardiac myocytes. Circulation. 1996;94:2560-2565.
20. Sato A, Canny BJ, Autelitano DL. Adrenomedullin stimulates cAMP accumulation and inhibits atrial natriuretic peptide gene expression in cardiomyocytes. Biochem Biophys Res Commun. 1997;230:311-314.
21. Morgan JP. Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction. N Engl J Med. 1991;325:625-632.
22. Samson WK, Murphy T, Schell DA. A novel vasoactive peptide, adrenomedullin, inhibits pituitary adrenocorticotropin release. Endocrinology. 1995;136:2349-2352.
23. Hidaka H, Kobayashi R. Pharmacology of protein kinase inhibitors. Annu Rev Pharmacol Toxicol. 1992;32:377-397.
24. Ruskoaho H. Atrial natriuretic peptide: synthesis, release and metabolism. Pharmacol Rev. 1992;44:479-602.
25. Ruskoaho H. Effect of atenolol and pindolol on the phorbol ester-induced coronary vasoconstriction in the isolated perfused heart of the rat. Br J Pharmacol. 1988;94:573-583.
26. Kitamura K, Kangawa K, Tshiyama Y, Washimine H, Ichiki Y, Kawamoto M, Minamino N, Matsuo H, Eto T. Identification and hypotensive activity of proadrenomedullin N-terminal 20 peptide (PAMP). FEBS Lett. 1994; 351:35-37.
27. Chijiva T, Mishima A, Hagivara M, Hayashi K, Inoue T, Naito K, Toshioka T, Hidaka H. Inhibition of forskolin-induced neunte outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinoline sulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem. 1990;265:5267-5272.
28. 2+ release channel of sarcoplasmic reticulum. J Biol Chem. 1986;261:6300-6306.
29. 2+ release channel. Am J Physiol. 1987;253: C364-C368.
30. 2+-ATPase. Proc Natl Acad Sci U S A. 1990;87:2466-2470.
31. 2+-ATPase family of calcium pumps. J Biol Chem. 1991;266:17067-17071.
32. Kinnunen P, Vuolteenaho O, Ruskoaho H. Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching. Endocrinology. 1993;132:1961-1970.
33. Chaffman M, Brogden RN. Diltiazem: a review of its pharmacological properties and therapeutic efficacy. Drugs. 1985;29:387-454.
34. Laine M, Arjamaa O, Vuolteenaho O, Ruskoaho H, Weckström M. Block of stretch-activated atrial natriuretic peptide secretion by gadolinium in isolated rat atrium. J Physiol (Lond). 1994;480:553-561.
35. Vuolteenaho O, Arjaama O, Ling N. Atrial natriuretic polypeptides (ANP): rat atria store high molecular weight precursor but secrete processed peptides of 25-28 amino acids. Biochem Biophys Res Commun. 1985; 129:82-88.
36. Nakamura K, Toda H, Terasako K, Kakuyama M, Hatano Y, Mori K, Kangawa K. Vasodilative effect of adrenomedullin in isolated arteries of the dog. Jpn J Pharmacol. 1995;67:259-262.
37. Entzeroth M, Doods HN, Wieland HA, Wienen W. Adrenomedullin mediates vasodilation via CGRP1 receptors. Life Sci. 1995;56:19-25.
38. Keely SL, Corbin JD. Involvement of cAMP-dependent protein kinase in the regulation of heart contractile force. Am J Physiol. 1977;233: H269-H275.
39. Ishikawa T, Okamura N, Saito A, Masaki T, Goto K. Positive inotropic effect of calcitonin gene-related peptide mediated by cyclic AMP in guinea pig heart. Circ Res. 1988;63:726-734.
40. Berridge MJ. Inositol trisphosphate and calcium signalling. Nature. 1993; 361:315-325.
41. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 1995;9:484-496.
42. Yuan S, Sunahara FA, Sen AK. Tumor-promoting phorbol esters inhibit cardiac functions and induce redistribution of protein kinase C in perfused beating heart. Circ Res. 1987;61:372-378.
43. Pitkänen M, Mäntymaa P, Ruskoaho H. Staurosporine, a protein kinase C inhibitor, inhibits atrial natriuretic peptide secretion induced by sarafotoxin, endothelin and phorbol ester. Eur J Pharmacol. 1991;195: 307-315.
44. Tavi P, Laine M, Weckström M. Effect of gadolinium on stretch-induced changes in contraction and intracellularly recorded action- and afterpotentials of rat isolated atrium. Br J Pharmacol. 1996;118:407-413.
45. Taskinen P, Ruskoaho H. Stretch-induced increase in atrial natriuretic peptide secretion is blocked by thapsigargin. Eur J Pharmacol. 1996;308: 295-300.
46. Williamson R, Jamieson D. Dissociation of the inotropic from the glycogenolytic effect of epinephrine in the isolated rat heart. Nature. 1965;206: 364-367.
47. Moschella MC, Marks AR. Inositol 1,4,5-triphosphate receptor expression in cardiac myocytes. J Cell Biol. 1993;266:1109-1116.
48. 3-induced contractions by myoplasmic calcium in permeabilized atrial muscle. Cardiovasc Res. 1995; 30:905-914.
49. Fabiato A. Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. Am J Physiol. 1983;245:C1-C14.
50. Varro A, Papp JG. The impact of single cell voltage clamp on the understanding of the cardiac ventricular action potential. Cardioscience. 1992;3: 131-144.
51. Kapas S, Catt KJ, Clark AJL. Cloning and expression of cDNA encoding a rat adrenomedullin receptor. J Biol Chem. 1995;270:25344-25347.
52. Holman JJ, Craig RK, Marschall I. Human α- and β-CGRP, and rat α-CGRP are coronary vasodilators in the rat. Peptides. 1986;7:231-235.
53. Sugiyama A, Kobayashi M, Tsujimoto G, Motomura S, Hashimoto K. The first demonstration of CGRP-immunoreactive fibres in canine hearts: coronary vasodilator, inotropic and chronotropic effects of CGRP in canine isolated blood-perfused heart preparation. Jpn J Pharmacol. 1989;50: 421-427.
54. Inatsu H, Sakata J, Shimokubo T, Kitani M, Nishizono M, Washimine H, Kitamura K, Kangawa K, Matsuo H, Eto T. Biochem Mol. Biol Int. 1996; 38:365-372.
55. Iwasaki H, Hirata Y, Iwashina M, Sato K, Marumo F. Specific binding sites for proadrenomedullin N-terminal 20 peptide (PAMP) in the rat. Endocrinology. 1996;137:3045-3050.
56. Sugo S, Minamino N, Shoji H, Kangawa K, Matsuo H. Effects of vasoactive substances and cAMP related compounds on adrenomedullin production in cultured vascular smooth muscle cells. FEBS Lett. 1995;369: 311-314.
57. Kelly RA, Eid H, Krämer BK, O'Neill M, Liang BT, Reers M, Smith TW. Endothelin enhances the responsiveness of adult rat ventricular myocytes to calcium by a pertussis toxin-sensitive pathway. J Clin Invest. 1990;86: 1164-1171.
58. Takanashi M, Endoh M. Characterization of positive inotropic effect of endothelin on mammalian ventricular myocardium. Am J Physiol. 1991; 261:H611-H619.
59. Ikenouchi H, Kangawa K, Matsuo H, Hirata Y. Negative inotropic effect of adrenomedullin in isolated adult rabbit cardiac ventricular myocytes. Circulation. 1997;95:2318-2324.